Page last updated: 2024-08-24

fluorodopa f 18 and MEA 2a

fluorodopa f 18 has been researched along with MEA 2a in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chabrier, G; Imperiale, A; Rotania, M1
Dollé, F; Ducongé, F; Gombert, K; Kuhnast, B; Le Helleix, S; Pestourie, C; Tavitian, B; Thézé, B1

Other Studies

2 other study(ies) available for fluorodopa f 18 and MEA 2a

ArticleYear
Synchronous bilateral pheochromocytomas and bilobar medullary thyroid carcinoma revealed by
    Endocrine, 2019, Volume: 66, Issue:3

    Topics: Adrenal Gland Neoplasms; Adult; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Multiple Endocrine Neoplasia Type 2a; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms

2019
PET imaging of medullary thyroid carcinoma in MEN2A transgenic mice using 6-[(18)F]F-L-DOPA.
    European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:1

    Topics: Animals; Carcinoma, Medullary; Dihydroxyphenylalanine; Mice; Mice, Transgenic; Multiple Endocrine Neoplasia Type 2a; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms

2010